Skip to main content
. 2017 Jun 19;8(66):109915–109923. doi: 10.18632/oncotarget.18565

Figure 4. Methylation analysis of ASNS CpG.

Figure 4

(A) Example of ALL cell lines with ASNS promoter hypermethylated (DND-41). (B) Example of ALL cell line with ASNS promoter hypomethylated (CCRF-CEM). (C) Example of AML cell line with -7 and with ASNS promoter hypomethylated (UCSD-AML1). (D) Example of other AML cell line without -7 and with ASNS promoter hypomethylated (MOLM-13).